# \[e-drug\] WHO Conference on Policies on Pricing etc (cont)

**URL:** <https://talk.edrugplus.org/t/e-drug-who-conference-on-policies-on-pricing-etc-cont/9474>\
**Category:** e-drug\
**Created:** [October 28, 2000, 9:23am UTC](https://talk.edrugplus.org/t/e-drug-who-conference-on-policies-on-pricing-etc-cont/9474 "2000-10-28T09:23:25Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Joncheere\_Kees\_de\_QC](https://avatars.discourse-cdn.com/v4/letter/j/57b2e6/32.png) [@Joncheere\_Kees\_de\_QC](https://talk.edrugplus.org/u/Joncheere_Kees_de_QC)\
**Post date:** [October 28, 2000, 9:23am UTC](https://talk.edrugplus.org/t/e-drug-who-conference-on-policies-on-pricing-etc-cont/9474/1 "2000-10-28T09:23:25Z")

</div>

E-drug: WHO Conference on Policies on Pricing etc (cont)  
---------------------------------------------  
Dear e-druggers,

on November 16-17 WHO European Regional Office is organising a  
meeting with the Ministries of Health and Social Health Insurance  
Institutions, for the officials responsible for pharmaceutical  
reimbursement and pricing policies.

This meeting is a follow-up of a 1999 WHO/EURO explorative meeting  
with Ministries of Health and social health insurance authorities  
from Member States to discuss the emerging use of pharmaco-economics  
in the decision-making procedures in the reimbursement systems. The  
meeting concluded on the usefulness of applying pharmaco- and health  
economic guidance as one of the criteria in the reimbursement  
decisions, but also recognized the considerable methodological  
difficulties in developing the guidelines and interpreting the  
results of the studies. Possible areas for further work include :  
experiences with pharmaco-economic guidelines and guidance;  
reimbursement criteria; information exchange on drug prices;  
reimbursement status and additional conditions; rational use of medicines ;  
and policies on generic drugs.

In response to this the WHO/EURO is convening this meeting that will  
provide a forum for high level pharmaceutical policy makers from  
Ministries of Health and social health insurance from European member  
countries to discuss these pharmaceutical policy issues and  
challenges, to analyse the potential areas for further information  
exchange and international collaboration, and to develop more  
concrete proposals in that respect.

The report of the meeting will posted on the internet, and I will  
alert you in due time.

You also may wish to look at the report of the EU conference on  
"Medicines and Public Health" at [http://www.infarmed.pt/home.html](http://www.infarmed.pt/home.html)

best wishes

Kees de Joncheere  
Regional Adviser for Pharmaceuticals  
WHO/EURO  
8 Scherfigsvej, 2100 Copenhagen, DK  
tel 45-39171528/39171432  
fax 45-39171855  
email cjo@who.dk  
[http://www.who.dk/ch/pha](http://www.who.dk/ch/pha)

--  
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.  
Mail administrative requests to `majordomo@usa.healthnet.org'.  
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
